(Q44004556)

English

Tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short-term low-molecular-weight heparin administration

scientific article published in June 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short-term low-molecular-weight heparin administration (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

unstable angina

1 reference

based on heuristic

inferred from title

Anna Maria Gori

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Domenico Prisco

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Fedi S

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Pepe G

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Falciani M

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Rogolino A

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Gensini GF

7

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Abbate R

8

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

1 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

117

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

693-698

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Comparison of plasma tissue factor levels in unstable and stable angina pectoris.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Randomised comparison of subcutaneous heparin, intravenous heparin, and aspirin in unstable angina. Studio Epoorine Sottocutanea nell'Angina Instobile (SESAIR) Refrattorie Group.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Vastatins Inhibit Tissue Factor in Cultured Human Macrophages

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Plasma Protein Acute-Phase Response in Unstable Angina Is Not Induced by Ischemic Injury

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Transient intermittent lymphocyte activation is responsible for the instability of angina

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Tissue-factor antigen and activity in human coronary atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Elevation of C-reactive protein in "active" coronary artery disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Unstable angina. A classification

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Thrombogenic factors and recurrent coronary events

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Effects of enalapril on tissue factor in patients with uncomplicated acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Plasma tissue factor pathway inhibitor and tissue factor antigen levels after administration of heparin in patients with angina pectoris

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03522.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2002.03522.X

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44004556&oldid=2105565892"